Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Financings Of The Fortnight Looks For A Strong IPO Year To Pick Up Further In Second Half

Jul 29 2013

• By Alex Lash, Lisa LaMotta, and Beth Allan

Related Content

START-UP's 2011 Life Science Venture Capital Survey: Biopharmaceutical Investors Let Some Sunshine In

Sep 01 2011

Celgene Teams Up With Agios In Long-Term Cancer Metabolism Pact

May 01 2010

Alnara Execs Start Anew With Allena; $15 M Series A

Nov 16 2011

Alcresta Infused With $10M Series B To Get First Product To Market

Jul 22 2013

Related Companies

Genetix Biotherapeutics

Epizyme, Inc.

Prosensa Holding N.V

Agios Pharmaceuticals, Inc.

Verastem, Inc.

Regulus Therapeutics Inc.

Bristol Myers Squibb Company

Merrimack Pharmaceuticals, Inc.

OncoMed Pharmaceuticals, Inc.

GSK plc

Alcresta Therapeutics, Inc.

Allena Pharmaceuticals Inc.

Additional Topics

Business Strategies

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window